MORRISVILLE, North Carolina, February 9, 2017 /PRNewswire/ --
Worldwide Clinical Trials (http://www.worldwide.com)
On Thursday, February 16 at 11 a.m. ET, Worldwide will host its Heart Month webinar titled, "The Future in Heart Failure: Novel Therapies, Innovative Trial Designs & Stakeholder Diversity." Participants will hear from Michael Murphy, M.D., Ph.D., Chief Medical & Scientific Officer at Worldwide, and Toni Bransford, M.D., Senior Medical Director, Medical & Scientific Affairs at Worldwide. They will discuss a range of topics including emerging heart failure therapies and trial designs; how to demonstrate value when novelty is not enough; and the who, what and why of diverse stakeholders.
The next webinar in the series will celebrate Rare Disease Day on Tuesday, February 28 at 11 a.m. ET. The webinar, titled "Rare Disease Clinical Trials: An Opportunity for Differentiated Services," will be hosted by Dr. Murphy, who will be joined by Leslie Wetherell, Executive Director, Project Management, Rare Disease Franchise Lead at Worldwide. They will discuss emerging opportunities for an "outside the box" approach to both study and program design; how family engagement informs both trial design and operational strategy; and how innovative development strategies necessitate efficient, high quality program execution.
Both webinars are free to attendees. To learn more, visit http://www.worldwide.com/webinars or register directly at:
Connect with Worldwide Clinical Trials:
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit Worldwide.com.
SOURCE Worldwide Clinical Trials
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All